Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Emolienta is a line of dermatological products developed by Laboratorios Viñas, specifically formulated to treat dry skin (xerosis), sensitive skin, and related conditions. The primary formulations typically contain a combination of urea, lactic acid, sodium hyaluronate, and squalane. These ingredients work synergistically to restore the skin's hydrolipidic film, enhance hydration, and improve skin barrier function. Urea and lactic acid act as natural moisturizing factors (NMF) that enhance water retention in the stratum corneum, while sodium hyaluronate provides intense hydration and squalane replenishes essential lipids to restore the protective lipid layer. The product range includes specialized formulations for hands, lips, eyelids, and nails, providing intensive moisturizing and protective effects for sensitive or damaged skin.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Emolienta.